Testing effectiveness (Phase 2)Looking for participantsNCT07089992What this trial is testingPembrolizumab in People With Ultra-Rare SarcomasWho this might be right forSarcoma Memorial Sloan Kettering Cancer Center 32
Testing effectiveness (Phase 2)Looking for participantsNCT06239272What this trial is testingNRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)Who this might be right forAdipocytic NeoplasmLiposarcomaAtypical Fibroxanthoma+6 more St. Jude Children's Research Hospital 139
Testing effectiveness (Phase 2)UnknownNCT05266196What this trial is testingA Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)Who this might be right forEwing SarcomaMyxoid LiposarcomaDesmoplastic Small Round Cell Tumor+6 more Salarius Pharmaceuticals, LLC 10
Large-scale testing (Phase 3)Active Not RecruitingNCT02180867What this trial is testingRadiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by SurgeryWho this might be right forAlveolar Soft Part SarcomaAngiomatoid Fibrous HistiocytomaAtypical Fibroxanthoma+33 more National Cancer Institute (NCI) 140
Not applicableLooking for participantsNCT03967834What this trial is testingMultimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma GroupWho this might be right forSoft Tissue SarcomaClear Cell SarcomaEpithelioid Sarcoma+7 more Institut Claudius Regaud 400
Early research (Phase 1)UnknownNCT03600649What this trial is testingClinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related SarcomasWho this might be right forEwing SarcomaMyxoid LiposarcomaSarcoma,Soft Tissue+8 more Salarius Pharmaceuticals, LLC 50